These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 30187382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA, McRae JL, Dwyer KM.
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A, Pieruzzi F, Trezzi B, Ghiggeri G, Napodano P, D'Amico M, Stellato T, Brugnano R, Ravera F, Rolla D, Pesce G, Giovenzana ME, Londrino F, Cantaluppi V, Pregnolato F, Volpi A, Rombolà G, Moroni G, Ortisi G, Sinico RA.
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study.
    Li C, Li P, Guo W, Chen L, Li J, Wang R, Chen B.
    Korean J Intern Med; 2022 Jan; 37(1):154-166. PubMed ID: 32972118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA.
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [Abstract] [Full Text] [Related]

  • 10. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N, Cao Y, Dai H, Yuan L, Shi L, Zhang Y.
    Med Sci Monit; 2019 Dec 09; 25():9364-9368. PubMed ID: 31813930
    [Abstract] [Full Text] [Related]

  • 11. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q, Huang B, Liu X, Liu B, Zhang Y, Zhang Z, Hua J, Fan Y, Hu L, Meng M, Wu M, Wang L, Hu Z, Sun Z.
    Sci Rep; 2017 Sep 21; 7(1):12049. PubMed ID: 28935926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method.
    Dou Y, Zhang L, Liu D, Wang C, Quan S, Ma S, Xiao J, Cheng G, Liu Z, Zhao Z.
    Int Urol Nephrol; 2016 Jun 21; 48(6):845-9. PubMed ID: 27017339
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V.
    Nephrology (Carlton); 2015 Aug 21; 20(8):572-5. PubMed ID: 26194981
    [Abstract] [Full Text] [Related]

  • 15. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L.
    Vasc Health Risk Manag; 2018 Aug 21; 14():103-108. PubMed ID: 29881283
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 3 anti-PLA2R inmmunoassaysfor the diagnosis of idiopathic membranous nephropathy in an european population. A pilot study.
    Nieto-Gañán I, Rita CG, Villacorta-Pérez J, Ortego-Pérez S, Rodríguez-Mendiola N, Carrasco-Sayalero Á.
    Clin Immunol; 2021 Jun 21; 227():108729. PubMed ID: 33872763
    [Abstract] [Full Text] [Related]

  • 17. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, Poulton K, McWilliam L, Short CD, Venning M, Brenchley PE.
    Kidney Int; 2013 May 21; 83(5):940-8. PubMed ID: 23364522
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF, Blasco M, Seras M, Pérez NS, López-Hoyos M, Villarroel P, Rodrigo E, Viñas O, Ercilla G, Diekmann F, Gómez-Roman JJ, Fernandez-Fresnedo G, Oppenheimer F, Arias M, Campistol JM.
    Transplantation; 2015 Aug 21; 99(8):1709-14. PubMed ID: 25675198
    [Abstract] [Full Text] [Related]

  • 19. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L.
    Ren Fail; 2022 Dec 21; 44(1):428-433. PubMed ID: 35272568
    [Abstract] [Full Text] [Related]

  • 20. Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.
    Burbelo PD, Beck LH, Waldman M.
    J Immunol Methods; 2017 May 21; 444():17-23. PubMed ID: 28167276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.